Signs of a tide: two Israeli venture funds raise capital

It’s not very often that two Israeli venture funds complete closing for additional funds, but after all it shouldn’t surprise anyone. Israel has been ranked among the four most preferred global target markets for US venture capital funds and earmarked for high-quality deal flow, according to a global survey by accounting and consultancy firm Deloitte Brightman Almagor and the Israel Venture Association.

Two funds reported closings today:

gemini logo1) Gemini Israel Funds has closed $140 million for its fifth fund. The company plans to raise $200 million altogether. All together this would put Gemini right under $700 million under management.

‘Globes’ reports that Yossi Sela, a managing partner at Gemini confirmed the report.

“Gemini has indeed made the first closing and is continuing to raise capital for its fifth fund. Gemini will continue its stable strategy and mainly investment in early-stage companies.”

giza vc logo2) EE Times reports that Taiwan is helping Giza Venture Capital raise capital for its fifth fund. Israel-based Giza Ventures in planning to raise $150 million, of which $30 million are due to come from the Taiwan government’s National Development Fund (NDF). Giza was established in 1992 and currently manages four funds of approximately $500 million under management.

Gemini and Giza are not alone. Pitango Venture Capital recently raised $300 million for its fifth fund a few months ago.

Eze Vidra
Follow me

Eze Vidra

Chief Innovation Officer at Antidote
Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Ezewas a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.
Eze Vidra
Follow me

Eze Vidra

Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Eze was a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.